AREV Stock Overview
Operates as an early-stage life science discovery company in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
AREV Life Sciences Global Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.09 |
| 52 Week High | CA$0.27 |
| 52 Week Low | CA$0.065 |
| Beta | 2.62 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -35.71% |
| 3 Year Change | 28.57% |
| 5 Year Change | -95.71% |
| Change since IPO | -94.23% |
Recent News & Updates
Shareholder Returns
| AREV | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -3.7% |
| 1Y | -35.7% | -24.4% | 15.0% |
Return vs Industry: AREV underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: AREV underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| AREV volatility | |
|---|---|
| AREV Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: AREV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AREV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Mike Withrow | www.arevlifesciences.com |
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. The company’s CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles. Its ingredients are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets.
AREV Life Sciences Global Corp. Fundamentals Summary
| AREV fundamental statistics | |
|---|---|
| Market cap | CA$2.86m |
| Earnings (TTM) | -CA$1.02m |
| Revenue (TTM) | CA$183.89k |
15.5x
P/S Ratio-2.8x
P/E RatioIs AREV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AREV income statement (TTM) | |
|---|---|
| Revenue | CA$183.89k |
| Cost of Revenue | CA$15.66k |
| Gross Profit | CA$168.23k |
| Other Expenses | CA$1.19m |
| Earnings | -CA$1.02m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 91.48% |
| Net Profit Margin | -555.81% |
| Debt/Equity Ratio | -4.4% |
How did AREV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/16 18:18 |
| End of Day Share Price | 2023/07/20 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AREV Life Sciences Global Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|